Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasia
- PMID: 22125178
- PMCID: PMC3256283
- DOI: 10.1002/bdra.22869
Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasia
Abstract
Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants born extremely preterm, typically before 28 weeks' gestation, characterized by a prolonged need for supplemental oxygen or positive pressure ventilation beyond 36 weeks postmenstrual age. The limited number of autopsy samples available from infants with BPD in the postsurfactant era has revealed a reduced capacity for gas exchange resulting from simplification of the distal lung structure with fewer, larger alveoli because of a failure of normal lung alveolar septation and pulmonary microvascular development. The mechanisms responsible for alveolar simplification in BPD have not been fully elucidated, but mounting evidence suggests that aberrations in the cross-talk between growth factors of the lung mesenchyme and distal airspace epithelium have a key role. Animal models that recapitulate the human condition have expanded our knowledge of the pathology of BPD and have identified candidate matrix components and growth factors in the developing lung that are disrupted by conditions that predispose infants to BPD and interfere with normal vascular and alveolar morphogenesis. This review focuses on the deviations from normal lung development that define the pathophysiology of BPD and summarizes the various candidate mesenchyme-associated proteins and growth factors that have been identified as being disrupted in animal models of BPD. Finally, future areas of research to identify novel _targets affected in arrested lung development and recovery are discussed.
Copyright © 2011 Wiley-Liss, Inc.
Figures
Similar articles
-
Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants.Front Biosci. 2003 May 1;8:e370-80. doi: 10.2741/1060. Front Biosci. 2003. PMID: 12700058 Review.
-
Cumulative effects of neonatal hyperoxia on murine alveolar structure and function.Pediatr Pulmonol. 2017 May;52(5):616-624. doi: 10.1002/ppul.23654. Epub 2017 Feb 10. Pediatr Pulmonol. 2017. PMID: 28186703 Free PMC article.
-
Progenitor cells of the distal lung and their potential role in neonatal lung disease.Birth Defects Res A Clin Mol Teratol. 2014 Mar;100(3):217-26. doi: 10.1002/bdra.23227. Epub 2014 Mar 12. Birth Defects Res A Clin Mol Teratol. 2014. PMID: 24619857 Review.
-
Membrane and Capillary Components of Lung Diffusion in Infants with Bronchopulmonary Dysplasia.Am J Respir Crit Care Med. 2016 Apr 1;193(7):767-71. doi: 10.1164/rccm.201506-1219OC. Am J Respir Crit Care Med. 2016. PMID: 26566056 Free PMC article.
-
Postnatal Sepsis and Bronchopulmonary Dysplasia in Premature Infants: Mechanistic Insights into "New BPD".Am J Respir Cell Mol Biol. 2022 Feb;66(2):137-145. doi: 10.1165/rcmb.2021-0353PS. Am J Respir Cell Mol Biol. 2022. PMID: 34644520 Free PMC article. Review.
Cited by
-
Identification of a FGF18-expressing alveolar myofibroblast that is developmentally cleared during alveologenesis.Development. 2020 Jan 17;147(2):dev181032. doi: 10.1242/dev.181032. Development. 2020. PMID: 31862844 Free PMC article.
-
Epithelial-mesenchymal co-culture model for studying alveolar morphogenesis.Organogenesis. 2014;10(4):340-9. doi: 10.4161/org.29198. Epub 2014 Oct 31. Organogenesis. 2014. PMID: 25482312 Free PMC article.
-
Periostin downregulation is an early marker of inhibited neonatal murine lung alveolar septation.Birth Defects Res A Clin Mol Teratol. 2013 Jun;97(6):373-85. doi: 10.1002/bdra.23149. Epub 2013 May 30. Birth Defects Res A Clin Mol Teratol. 2013. PMID: 23723163 Free PMC article.
-
Hedgehog and Platelet-derived Growth Factor Signaling Intersect during Postnatal Lung Development.Am J Respir Cell Mol Biol. 2023 May;68(5):523-536. doi: 10.1165/rcmb.2022-0269OC. Am J Respir Cell Mol Biol. 2023. PMID: 36693140 Free PMC article.
-
The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant.Stem Cells Int. 2018 Apr 8;2018:9652897. doi: 10.1155/2018/9652897. eCollection 2018. Stem Cells Int. 2018. PMID: 29765429 Free PMC article. Review.
References
-
- Alapati D, Rong M, Chen S, Hehre D, Rodriguez MM, Lipson KE, Wu S. CTGF Antibody Therapy Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats. Am J Respir Cell Mol Biol. 2011 - PubMed
-
- Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho SC, Carlton DP, Bland RD. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med. 1999;159(3):945–958. - PubMed
-
- Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell. 4th ed. New York: Garland Science; 2002. The Extracellular Matrix of Animals.
-
- Alejandre-Alcázar MA, Kwapiszewska G, Reiss I, Amarie OV, Marsh LM, Sevilla-Pérez J, Wygrecka M, Eul B, Köbrich S, Hesse M, Schermuly RT, Seeger W, Eickelberg O, Morty RE. Hyperoxia modulates TGF-Beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2007;292(2):L537–L549. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical